 
                        | Product NDC: | 0703-4766 | 
| Proprietary Name: | Paclitaxel | 
| Non Proprietary Name: | Paclitaxel | 
| Active Ingredient(s): | 6 mg/mL & nbsp; Paclitaxel | 
| Administration Route(s): | INTRAVENOUS | 
| Dosage Form(s): | INJECTION, SOLUTION | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 0703-4766 | 
| Labeler Name: | Teva Parenteral Medicines, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA075184 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20080924 | 
| Package NDC: | 0703-4766-01 | 
| Package Description: | 1 VIAL, MULTI-DOSE in 1 CARTON (0703-4766-01) > 16.7 mL in 1 VIAL, MULTI-DOSE | 
| NDC Code | 0703-4766-01 | 
| Proprietary Name | Paclitaxel | 
| Package Description | 1 VIAL, MULTI-DOSE in 1 CARTON (0703-4766-01) > 16.7 mL in 1 VIAL, MULTI-DOSE | 
| Product NDC | 0703-4766 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Paclitaxel | 
| Dosage Form Name | INJECTION, SOLUTION | 
| Route Name | INTRAVENOUS | 
| Start Marketing Date | 20080924 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Teva Parenteral Medicines, Inc. | 
| Substance Name | PACLITAXEL | 
| Strength Number | 6 | 
| Strength Unit | mg/mL | 
| Pharmaceutical Classes | Microtubule Inhibition [PE],Microtubule Inhibitor [EPC] |